ENT Devices are used to diagnose and treat disorders related to ear, nose and throat. Balloon Sinuplasty Systems, also known as Balloon Dilation Catheter Systems or Sinus Dilation Systems, are devices which are used to open blocked sinus passages using balloon catheters & inflation devices. GlobalData uses proprietary data and analytics to provide a comprehensive report on the balloon sinuplasty systems devices market, including market shares of different players within New Zealand. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the balloon sinuplasty systems market in New Zealand was Acclarent followed by Medtronic and Entellus Medical.
Balloon Sinuplasty is a minimally invasive technique is used to treat chronic sinusitis or sinus infections when medical therapy has not provided adequate relief. During this intervention, the surgeon places a small balloon through the nose, which dilates the sinus openings. The results are permanent, and it does not require implants or additional support.
The value of the balloon sinuplasty systems devices market within New Zealand was expected to be over $1m in 2023.
For the latest complete market share analysis of balloon sinuplasty systems device market in New Zealand, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
